Invista 50 mg Tablet
  1. Home
  2. Pharma Products
  3. Dr Reddy 's Laboratories Ltd
  4. Invista 50 mg Tablet

Invista 50 mg Tablet

Invista 50 mg Tablet contains dasatinib 50 mg, a targeted anticancer medicine used for certain blood cancers. It is an oral tablet taken according to the treatment plan prescribed by the oncologist. Dasatinib blocks abnormal tyrosine kinase proteins involved in leukemia-cell growth.

BUY NOW

Category

Invista 50 mg Tablet is used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Dasatinib belongs to the tyrosine kinase inhibitor class and inhibits BCR-ABL and related kinase activity involved in abnormal cell proliferation. The dosage and treatment duration are determined by the treating specialist according to the type and phase of leukemia and the patient’s response. Invista 50 mg is marketed by Dr. Reddy’s Laboratories Ltd. and is listed in a 10-tablet strip in India.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 50 mg
Dosage Form Film-Coated Tablet
Route Oral
Pack Size 10 Tablets
Manufacturer/Marketer Dr. Reddy’s Laboratories Ltd.

Product Also Known As

Invista 50 mg Tablet, Invista 50 Tablet, Invista Dasatinib Tablet, Dasatinib 50 mg Tablet, Dasatinib Leukemia Tablet, Dasatinib Tyrosine Kinase Inhibitor Tablet